Higginbotham Eve J

Assessment of Cumulative Incidence and Severity of Primary Open-Angle Glaucoma Among Participants in the Ocular Hypertension Treatment Study After 20 Years of Follow-up.

In this study, only one-fourth of participants in the Ocular Hypertension Treatment Study developed visual field loss in either eye over long-term follow-up.

Is Newer Necessarily Better? The Evolution of Incisional Glaucoma Surgery Over the Last 100 Years.

Appropriate patient selection, careful attention to surgical technique, and intensive follow-up of patients will optimize the results of a trabeculectomy.

Assessment of the Impact of an Endpoint Committee in the Ocular Hypertension Treatment Study.

Endpoint Committee adjudication of endpoints improved POAG incidence estimates, increased statistical power, and increased calculated treatment effect by 23%.

What Does Telemedicine Mean for the Care of Patients With Glaucoma in the Age of COVID-19?

Visual Field Progression in the Ocular Hypertension Treatment Study.

Some participants in OHTS had rapid rates of VF loss in one or both eyes despite being followed in a clinical study.

Quality of Life and Primary Open-Angle Glaucoma in the Ocular Hypertension Treatment Study.

In this cross-sectional study, among the surviving participants of OHTS who completed the 20-year follow-up examination, those participants who developed preperimetric POAG but no glaucomatous VF loss did not report lower VFQoL compared with participants who did not develop POAG.

Striving Toward Better Eye Health Beyond Our Waiting Rooms: The LXXX Edward Jackson Memorial Lecture.

The characterization of study populations in the ophthalmic literature is limited by underreporting of patient-centered outcomes, useful for reaffirming the value of eye and vision health in population health.

Visual Field Progression Is More Complicated Than Meets the Eye.

Shaping Patients' Perspective of Medical Marijuana for Glaucoma Treatment.